Search clinical trials for: ACC/AHA
Total 7 results
-
Masonic Cancer Center, University of MinnesotaWithdrawnHIV-1-infection | ART | Interleukin | Cd4+ Lymphocyte Deficiency | Lymphoid Tissue; InfectionUnited States
-
Diskapi Yildirim Beyazit Education and Research...Completed
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedChest Pain | Acute Coronary SyndromeUnited States
-
Boston Scientific CorporationCompletedACC/AHA/NASPE Class 1, IIa or IIb IndicationsNetherlands, Italy, United Kingdom, New Zealand
-
Duke UniversitySanofi; Regeneron PharmaceuticalsCompletedSmoking | Stroke | Hypertension | Cardiovascular Disease | Diabetes | Peripheral Arterial Disease | Atherosclerosis | Carotid Stenosis | Hypercholesterolemia | Hyperlipidemia | Claudication | Unstable Angina | Coronary Artery Disease (CAD) | Chronic Kidney Disease (CKD) | Angina | Transient Ischemic Attack (TIA) | Myocardial...United States
-
Medtronic Cardiac Rhythm and Heart FailureCompletedClass I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National GuidelinesUnited States, Netherlands, Japan, Serbia, Spain, Greece, Canada, India, Denmark, Czechia, South Africa, Malaysia, Austria, United Kingdom, Hungary, China, Australia, France, Italy
-
Sorin Group CanadaCompletedAny Patient Who Fulfills the Inclusion Criteria to be Implanted With a Dual Chamber Pacemaker Maybe Included in the Study as Per ACC/AHA GuidelinesCanada